The risk of MACE was reduced by 12% (HR 0.88, 95% CI 0.840.94) with GLP-1RAs and by 11% (HR 0.89, 95% CI 0.830.96) with SGLT2is compared with that in placebo groups, suggesting that GLP-1RAs and SGLT2is reduce the risk of MACE to a similar extent
Why GLP-1 users love this plan: GLP-1 optimized meals: gentle on digestion, no heavy or greasy foods High-protein, smaller servings to prevent nausea and overeating Supports faster weight loss and helps break plateaus No hunger, no forcing food, no complicated tracking Done in 3 days with a simple, clear plan *Includes done-for-you nutritional information and WW points Part of the Reset 3 Breakthrough System, this plan follows the proven SAFE eating framework to help GLP-1 users see real results fast
During inflammatory bowel disease, colonic cells ramp up PepT1 expressioncreating disease-specific targeting in research models
Lipotropic shots can be part of that discussion, but they should not be the whole conversation